Evidence map›Paper›PMID 40702442›Full record

Observational studyBMC geriatrics2025

Effect of infections, DNA methylation and telomere length on frailty trajectories in hospitalized older patients: the INFRAGEN study protocol.

Wenxiang Guo, Leonardo Bencivenga, Bruno Micael Zanforlini, Chiara Curreri, Maria Cristina Ferrara, Benedetta Maisano, Luca Tinelli, Laura Andreea Ceparano, Raffaella Merenda, Chiara Cosma and 19 more

Registry-linked trialAbstract readObservational StudyMulticenter Study
In one paragraph

Observational study in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06430073 (Effect of Infections and Global DNA Methylation on Frailty Trajectories in Hospitalized Older Patients), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06430073 unknown statusnot on this map

Effect of Infections and Global DNA Methylation on Frailty Trajectories in Hospitalized Older Patients: a Multicenter Observational Study (INFRAGEN)

TypeobservationalSponsorUniversity Hospital of FerraraRan2024 to 2026Enrolled340ConditionsAging, Frailty, Telomere Shortening, Inflammation
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Wenxiang Guo *School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Leonardo Bencivenga *Department of Translational Medical Sciences, University of Naples "Federico II", Naples, Italy.
Bruno Micael ZanforliniDepartment of Medicine (DIMED), University of Padua, Via Giustiniani 2, 35128, Padua, Italy. brunomicael.zanforlini@unipd.it.
Chiara CurreriDepartment of Medicine (DIMED), University of Padua, Via Giustiniani 2, 35128, Padua, Italy.
Maria Cristina FerraraSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Benedetta MaisanoSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Luca TinelliSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Laura Andreea CeparanoDepartment of Translational Medical Sciences, University of Naples "Federico II", Naples, Italy.
Raffaella MerendaDepartment of Translational Medical Sciences, University of Naples "Federico II", Naples, Italy.
Chiara CosmaDepartment of Medicine (DIMED), University of Padua, Via Giustiniani 2, 35128, Padua, Italy.
Lucia ManfronDepartment of Medicine (DIMED), University of Padua, Via Giustiniani 2, 35128, Padua, Italy.
Nicolò GentiliDepartment of Medicine (DIMED), University of Padua, Via Giustiniani 2, 35128, Padua, Italy.
Silvia SturaniDepartment of Medicine (DIMED), University of Padua, Via Giustiniani 2, 35128, Padua, Italy.
Monica CardiDepartment of Medical Science, University of Ferrara, Ferrara, Italy.
Alice CampionDepartment of Medical Science, University of Ferrara, Ferrara, Italy.
Benedetta BerardiDepartment of Medical Science, University of Ferrara, Ferrara, Italy.
Martina LombardiDepartment of Medical Science, University of Ferrara, Ferrara, Italy.
Elisabetta D'AversaDepartment of Translational Medicine, University of Ferrara, Ferrara, Italy.
Francesca SalvatoriDepartment of Translational Medicine, University of Ferrara, Ferrara, Italy.
Veronica TisatoDepartment of Translational Medicine, University of Ferrara, Ferrara, Italy.
Joanne Vanessa VargasDepartment of Translational Medicine, University of Ferrara, Ferrara, Italy.
Grazia Daniela FemminellaDepartment of Translational Medical Sciences, University of Naples "Federico II", Naples, Italy.
Donato GemmatiDepartment of Translational Medicine, University of Ferrara, Ferrara, Italy.
Giuseppe SergiDepartment of Medicine (DIMED), University of Padua, Via Giustiniani 2, 35128, Padua, Italy.
Giuseppe BellelliSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Paolo MazzolaSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Caterina TrevisanDepartment of Medical Science, University of Ferrara, Ferrara, Italy.
Stefano VolpatoDepartment of Medical Science, University of Ferrara, Ferrara, Italy.
INFRAGEN working group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfectious diseases are among the most common causes of hospitalization in older adults and may lead to a high burden on the individual's health and healthcare system. However, it is unclear whether and to which extent these events might affect frailty, fastening its development or hampering its reversion. The aims of the INFRAGEN project are 1) to assess the impact of acute infections on frailty trajectories in older inpatients, and 2) to evaluate the modifying effect of sociodemographic, clinical, functional, and genetic/epigenetic factors on that association.

methodsINFRAGEN is a multicenter prospective observational study that will be conducted in the acute Geriatric Units of four Italian centers (Ferrara, Padova, Monza, and Napoli). The project will involve individuals aged ≥ 70 with no or mild-to-moderate pre-admission frailty (Clinical Frailty Scale [CFS] < 6) and diagnosis of acute infectious diseases at the time of hospital admission or during hospitalization. For each participant, we will record data concerning the multidimensional geriatric assessment and the type and severity of infectious diseases (diagnosed according to ICD-9 codes). Blood samples will be collected to assess Global DNA methylation, Leukocyte Telomere Length (LTL), and levels of circulating markers associated with biological processes related to frailty (inflammatory state, dysmetabolism, brain modifications, and oxidative stress). Frailty status will be evaluated through the CFS and Frailty Index at admission (referring to the 2 weeks before hospitalization), hospital discharge, and after 3 months. In a subsample, genetic/epigenetic analyses will also be performed at the 3-month follow-up. DISCUSSION: INFRAGEN will contribute to exploring the complex pathophysiologic mechanisms of frailty in the context of infections in older adults through a translational approach. TRIAL REGISTRATIONS: NCT06430073 (ClinicalTrials.gov); Registration date: 2024-05-28.

Indexed as

Communicable DiseasesDNA MethylationFrail ElderlyFrailtyHospitalizationInfectionsTelomereTelomere HomeostasisAgedAged, 80 and overFemaleGeriatric AssessmentHumansItalyMaleProspective StudiesEpigenetic factorsFrailtyGeneticsInfectionsInflammation mediatorsLongitudinal study

Identifiers

PMID40702442
PMCPMC12285050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.